The greatest risk in AI-based health products is inaccurate or outdated information. To minimize this risk, OncoHub opens its knowledge base to periodic audit by an independent oncology advisory board.

The board approves clinical accuracy, ethical boundaries, and the currency of the knowledge base with a practical eye — not an academic one. Every update goes through board approval.

Advisory board members have been selected from the fields of medical oncology, pathology, medical genetics, surgical oncology, and psycho-oncology. This multidisciplinary structure supports the clinical credibility of both Compass and Council.

Clinical decisions always belong to the physician. OncoHub exists to support those decisions.